Other rare mutations have also been identified and some patients did not show any mutations in the RET oncogene, underlining as other genetic RET regions can potentially be involved (intronic regions, regulatory regions, etc.)or as other unknown genes may play a specific role in the pathogenesis of MTC. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.